Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REal-world Patterns of Treatment With CDKi 4/6 for AdVanced BrEast CAncer in PortugaL - REVEAL Study

NCT06463626 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT06463626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06463626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REal-world Patterns of Treatment With CDKi 4/6 for AdVanced BrEast CAncer in PortugaL - REVEAL Study
Lead sponsor
Novartis
Phase
Observational
Overall status
Completed
Start date
April 6, 2020
Completion date
June 27, 2023
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hormone-receptor-positive breast cancer, human epidermal growth factor 2 negative carcinoma of breast